Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2021

View Archived Issues

Researchers develop useful murine model of Bardet-Biedl syndrome

MDM2 and MDMX have a p53-independent role in cell-cycle progression in the absence of wild-type p53

Unveiling the evolutionary acquisition of antifungal drug resistance in Candida glabrata

QIMR describes CAR-T cells derived from CD49f+ T cells

Aptamer Sciences patents insulin receptor-specific aptamers

New HSD17B13 inhibitors identified at Inipharm

Glucagon receptor agonists discovered at Intarcia Therapeutics

Prelude Therapeutics presents new Mcl-1 inhibitors

Virulent factors of P. aeruginosa isolates are upregulated under anaerobic conditions

PKM2 is a novel regulator of brown fat adipogenesis

L-WNK1 inhibition as novel therapeutic strategy for protection from glomerular injury

ADX-097 displays targeted complement inhibition in tissues

Brain infections rare but brain symptoms common with SARS-CoV-2

CG-223 demonstrates antifibrotic effects in a murine model of pulmonary fibrosis

Cocrystal Pharma reports pan-viral activity of SARS-CoV-2 main protease inhibitors

MC4 receptor induces antipsychotic drug-related metabolic syndrome

PDS Biotechnology licenses rights to proprietary TARP antigen from NCI

Cybin reports positive preclinical data on deuterated psilocybin analogue

Verve announces preclinical data on GalNAc-LNP technology to deliver ANGPTL3 base editor in NHPs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...